Adamis receives European patent for novel cell-based cancers vaccine technology Adamis Pharmaceuticals Company , announced the technology which constitutes the basis of a novel cell-based cancer vaccine today, TeloB-VAX, was recently granted a patent in Europe. A patent entitled ‘Somatic transgene immunization and related methods’ has been issued apoteket . Although genetic vaccines have been used, there remains a need to develop even more effective solutions to exploit their capability to induce a reproducible immune response.
Several people suffer from a disorder referred to as metabolic syndrome, which includes symptoms such as hypertension and elevated bloodstream cholesterol. They are at threat of developing additional illnesses also, such as cardiovascular disease and diabetes mellitus. Obesity may, actually, be a major cause of each one of these problems – the query is, why? Kirsi H. The united team used lipidomics to review the fat tissue biopsies among several sets of monozygotic twins. In each twin set, one twin was obese , as the additional twin exhibited a standard body mass index. Because monozygotic twins share the same DNA and early upbringing, the effect of these factors on adult body mass phenotypes can be accounted for, leaving other factors such as adult lifestyle choices as the major variables.